# Treximet

NDC: 42847-850
Generic name: Sumatriptan Succinate and Naproxen Sodium
Labeler / Manufacturer: Currax Pharmaceuticals LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20080425

FDA application: NDA021926

## Active ingredients

- NAPROXEN SODIUM: 500 mg/1
- SUMATRIPTAN SUCCINATE: 85 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"42847-850"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=42847-850
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=42ddf376-8dc0-4236-be2a-0c6ae92ece04